Ledger.Open graph →
SEC Form D · filed November 4, 2021

Variant Bio, Inc

Offering
$105.0M
Sold
$95.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Josh Wolfe · Seattle, WADirectorAndrew Farnum · Seattle, WAExec · DirectorJulie Sunderland · Seattle, WADirectorBob More · Seattle, WADirectorStephane Castel · Seattle, WAExec · DirectorElena Viboch · Seattle, WADirectorStuart Nagae · Seattle, WADirectorGabriel Freifeld · San Diego, CADirectorCoby Lefkowitz · San Diego, CADirectorGold Roee · San Diego, CAExec · DirectorAnthony Choe · Beverly Hills, CADirectorThomas H. Davis · Hamilton, BermudaDirectorTravis Jordan · Greenwich, CTExec · DirectorLisheng Wang · Avon, CTDirectorKimball Carr · VIRGINIA BEACH, VADirectorPeter S. Lau · VIRGINIA BEACH, VADirectorCharles S. Keiser · VIRGINIA BEACH, VAExec · DirectorRichard S. Marten · Virginia Beach, VADirectorJames S. Coleman · Virginia Beach, VADirectorRichard Digirolamo · Natick, MAExec · DirectorMichael A. Hicklen · Birmingham, ALDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗